Tools & Technologies for Assessing Manual Therapies (SBIR [R43/R44])
The summary for the Tools & Technologies for Assessing Manual Therapies (SBIR [R43/R44]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Tools & Technologies for Assessing Manual Therapies (SBIR [R43/R44]): Purpose. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new or innovative uses of existing technology, or develop new technology, research tools, instruments, or devices to: 1) illuminate the mechanisms of action of the biological effects of manual therapies; 2) facilitate quantitative assessment of the local and systemic effects of manual therapies. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 3-5 projects awarded as a result of this announcement is $1 million for fiscal year 2009. Future year amounts will depend on annual appropriations. Budget and Project Period. For this funding opportunity
| Federal Grant Title: | Tools & Technologies for Assessing Manual Therapies (SBIR [R43/R44]) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-AT-09-003 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.213 |
| CFDA Descriptions: | Research and Training in Complementary and Alternative Medicine |
| Current Application Deadline: | Jun 01, 2009 |
| Original Application Deadline: | Jun 01, 2009 |
| Posted Date: | Feb 19, 2009 |
| Creation Date: | Feb 19, 2009 |
| Archive Date: | Jul 02, 2009 |
| Total Program Funding: | $1,000,000 |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Min...
- • HEAL Initiative: Integrative Management of chronic Pain and OUD for Whole Recovery (IMPOWR...
- • HEAL Initiative: Integrative Management of Chronic Pain and OUD for Whole Recovery (IMPOWR...
- • HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Bio...
- • HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery R...
- • Probiotics for Pediatric Illnesses
- • Cam Practitioner Research Education Project Grant Partnership
- • Complementary and Alternative Medicine Career Transition Award (K22)
- More Grants from the National Institutes of Health
- • HIV/AIDS Clinical Trials Network Statistical and Data Management Centers (UM1 Clinical Tri...
- • HIV/AIDS Clinical Trials Network Laboratory Centers (UM1 Clinical Trial Required)
- • HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)
- • HIV/AIDS Clinical Trials Network Leadership and Operations Centers (UM1 Clinical Trial Req...
- • Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional D...
